sglt2 semaglutide inhibitors and GLP-1 receptor agonists represent significant advances in the treatment of type 2 diabetes, but there are challenges in providing equitable access to these medicines… Retrospective comparison of the clinical
Description
The prevalence and risk of appendicitis Appendicitis affects about 7-8% of people at some point, a study onPMC found
Completely life changing
Always inform your GP or diabetes specialist nurse if you are considering probiotic supplementation, particularly if you have underlying health conditions
If taking a fiber supplement at night has kept you regular, continue it
